Valuation: Clover Corporation Limited

Market Cap 143M 98.61M 86.47M 79.7M 74.62M 140M 9.3B 958M 371M 4.6B 370M 362M 15.94B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 143M 98.61M 86.47M 79.7M 74.62M 140M 9.3B 958M 371M 4.6B 370M 362M 15.94B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.5x
Free-Float
81.15%
Yield 2026 *
2.09%
Yield 2027 * 2.79%
1 day-1.71%
1 week-3.37%
Current month-4.97%
1 month-4.44%
3 months+0.58%
6 months+5.52%
Current year+8.86%
1 week 0.86
Extreme 0.855
0.9
1 month 0.84
Extreme 0.835
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.49
Extreme 0.49
1.16
3 years 0.34
Extreme 0.337
1.23
5 years 0.34
Extreme 0.337
1.88
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
11-18Buy

Chief Executive Officer

529,638 0.3171%
11-18Sell

Chief Executive Officer

255,199 0.1528%
11-06Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%-3.37%+63.81%-28.93% 98.61M
-1.40%+5.64%+39.07%+92.08% 13.35B
-2.79%+6.05%-51.07%+147.20% 5.2B
-5.04%-5.91%-17.65%-61.11% 2.28B
-1.17%+6.63% - - 1.79B
+1.40%+22.09%-80.27%-68.00% 1.34B
+4.76%+5.38%+43.64%-6.07% 1.3B
+2.09%+12.45%+14.97%+36.01% 1.2B
+6.27%+3.40%-59.07%-62.64% 1.18B
-3.38%-4.50%-36.02%-28.63% 1.18B
Average -0.10%+2.80%-9.18%+2.21% 2.89B
Weighted average by Cap. -1.14%+1.91%+2.83%+62.26%

Financials

2026 *2027 *
Net sales 89.4M 61.73M 54.12M 49.89M 46.71M 87.58M 5.82B 600M 232M 2.88B 232M 227M 9.98B 95.3M 65.8M 57.69M 53.18M 49.79M 93.36M 6.21B 639M 247M 3.07B 247M 242M 10.64B
Net income - -
Net Debt - -
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
26/06/26 A$0.8600 -1.71% 46,795
25/06/26 A$0.8750 -0.57% 63,321
24/06/26 A$0.8800 -1.12% 24,280
23/06/26 A$0.8900 +1.14% 63,728
22/06/26 A$0.8800 -1.12% 12,866
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.8600AUD
Average target price
0.8700AUD
Spread / Average Target
+1.16%

Annual profits - Rate of surprise